Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
Mallick, U Harmer, C Yap, Beng K Wadsley, J Clarke, S Moss, L Nicol, A Clark, P Farnell, K McCready, R
Mallick, U
Harmer, C
Yap, Beng K
Wadsley, J
Clarke, S
Moss, L
Nicol, A
Clark, P
Farnell, K
McCready, R
Citations
Altmetric:
Abstract
It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid cancer or whether the effects of radioiodine (especially at a low dose) are influenced by using either recombinant human thyrotropin (thyrotropin alfa) or thyroid hormone withdrawal.
Authors
Mallick, U
Harmer, C
Yap, Beng K
Wadsley, J
Clarke, S
Moss, L
Nicol, A
Clark, P
Farnell, K
McCready, R
Smellie, J
Franklyn, J
John, R
Nutting, C
Newbold, K
Lemon, C
Gerrard, G
Abdel-Hamid, A
Hardman, J
Macias, E
Roques, T
Whitaker, S
Vijayan, R
Alvarez, P
Beare, S
Forsyth, S
Kadalayil, L
Hackshaw, A
Harmer, C
Yap, Beng K
Wadsley, J
Clarke, S
Moss, L
Nicol, A
Clark, P
Farnell, K
McCready, R
Smellie, J
Franklyn, J
John, R
Nutting, C
Newbold, K
Lemon, C
Gerrard, G
Abdel-Hamid, A
Hardman, J
Macias, E
Roques, T
Whitaker, S
Vijayan, R
Alvarez, P
Beare, S
Forsyth, S
Kadalayil, L
Hackshaw, A
Description
Date
2012-05-03
Publisher
Collections
Keywords
Type
Article
Citation
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. 2012, 366 (18):1674-85 N Engl J Med